Joseph G. Teague

NeoMed Technologies, Inc. develops a medical diagnostic device for coronary artery disease (CAD). It offers CAD Diagnostics, a diagnostic device that detects CAD without stressing the patient before symptoms occurs. The company was founded by Harry Bishop in August 2000 and is headquartered in Cleveland, OH.

Midwest Tooling Group provides high-quality tooling for the plastics industry. The private company is based in Chagrin Falls, OH.

Polychem LLC manufactures poly strapping and strapping machines. It products include plastic tools and accessories, pallet strapping equipment, steel strapping, orbital wrapper, and steel tools and accessories. The firm also specializes in four areas which include ultraviolet resin curing systems, epoxy resins, waterbourne resin systems, and polyester casting resins. The company was founded in 1974 and is headquartered in Mentor, OH.

Imalux, the medical device company on a mission. They're leading the world in the development of Optical Coherence Tomography (OCT), a breakthrough medical imaging modality used to visualize tissue microstructure in real-time, at the site of patient care. With the Niris Imaging System, its first generation OCT solution, Imalux provides physicians and surgeons a valuable tissue-profiling tool to assist in the diagnosis, treatment, and surveillance of disease. Currently, clinicians do not have effective imaging methods for detecting tissue structure abnormalities in a timely manner and at the point-of-care. Physicians, therefore, must rely on prior imaging studies and visual findings to guide surgery and treatment. There exists an unmet need for real-time, high spatial resolution medical imaging that can be used in a wide range of applications and practice settings at a reasonable cost. Globally, the healthcare community is searching for ways to streamline the delivery of care without compromising clinical outcomes. The Imalux Niris Imaging System offers clinicians the ability to 'see and treat' in a single patient visit a single episode of care. Imalux is developing products and services to address this serious clinical need that cannot be satisfied by current technologies. In time, Imalux anticipates that Optical Coherence Tomography will take its place alongside x-ray, ultrasound, Magnetic Resonance Imaging (MRI), Computerized Axial Tomography (CT scans), and nuclear medicine as the 'sixth imaging modality.' At present, research efforts continue as Imalux conducts further studies to establish the value of OCT in clinical settings and lead to eventual commercialization of the technology.